Clinical Trials Browser

Has results × durvalumab × Tumor-Agnostic × Clear all

NCT03842228 2025-10-14

COD

Phase 1 Active not recruiting

39 enrolled 15 charts

Neoplasm Metastasis

NCT02671435 2025-07-22

A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors

Phase 1/2 Active not recruiting

383 enrolled 48 charts

Neoplasm Metastasis

NCT03094286 2024-06-24

Durvalumab in HIV-1 Patients With Solid Tumors

Phase 2 Completed

20 enrolled 36 charts

Neoplasms